Publications by authors named "A Miyakawa"
Article Synopsis
- * The researchers developed a new method called TRISCO, which helps retain RNA signals in cleared organs for better imaging, specifically for whole-brain 3D RNA visualization.
- * TRISCO effectively preserves RNA integrity, ensures uniform labeling, and enhances tissue transparency, making it a powerful tool for detailed transcriptional spatial analysis at the single-cell level across various organs.
Article Synopsis
- SBRT (Stereotactic body radiation therapy) is shown to be less invasive and more cost-effective compared to surgery for treating operable stage I non-small cell lung cancer (NSCLC) in Japan.
- In a study, SBRT resulted in lower treatment costs by about $4,444 and improved quality-adjusted life years (QALYs) by 0.131 compared to surgery, with an overall survival rate of 78.2% versus 74.8%.
- The findings suggest SBRT is a preferred treatment option, but further large-scale studies are necessary to confirm these results.
Objective: There is no consensus on the optimal treatment for patients with locoregional recurrence of esophageal cancer after surgery. The objective of this study was to investigate the outcomes and prognostic factors associated with salvage radiotherapy in patients with locoregional recurrence of esophageal cancer after surgery.
Methods: We reviewed 80 patients with locoregional recurrence of esophageal cancer after surgery who were treated with radiotherapy.
Upper tract urothelial carcinoma (UTUC) is a rare form of urothelial cancer with a high incidence of recurrence and a low survival rate. Almost two-thirds of UTUCs are invasive at the time of diagnosis; therefore, improving diagnostic methods is key to increasing survival rates. Histopathological analysis of UTUC is essential for diagnosis and typically requires endoscopy biopsy, tissue sectioning, and labeling.
View Article and Find Full Text PDFWe compared survival outcomes of high-dose concomitant boost radiotherapy (HDCBRT) and conventional dose radiotherapy (CRT) for newly diagnosed glioblastoma (GB). Patients treated with intensity-modulated radiation therapy for newly diagnosed GB were included. In HDCBRT, specific targets received 69, 60, and 51 Gy in 30 fractions, while 60 Gy in 30 fractions was administered with a standard radiotherapy method in CRT.
View Article and Find Full Text PDF